Thursday, May 28, 2015
Genelux Announces Positive Phase 1 Data for Viral-Based Cancer Therapy
… intrapleurally for head and neck cancer, and mesothelioma, according to Genelux’s … exploring the area of cancer virotherapy, where one disease is harnessed and … : that the pathogen “poses no risk of host-cell integration” and can …
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment